Publication List Jan 2018-Dec 2018 Department of Pathology ... · Wang Y, Auger M, Kanber Y, Caglar D, Brimo F. Implementing the Paris System For Reporting Urinary Cytology results

Publication List Jan 2018-Dec 2018

Department of Pathology, McGill University

ALAMELDIN, M.

Ghaith J, Raslan IA, Szilagyi A, Alameldin M. Case of olmesartan-associated enteropathy and transient

positive antitissue transglutaminase serology. BMJ Case Rep. 2018 Dec 13;11(1). Pii: e225518.

Wang H, Agulnik J, Kasymjanova G, Wang A, Jiménez P, Cohen V, Small D, Pepe C, Sakr L, Fiset PO,

Auger M, Camilleri-Broët S, Alam El Din M, Chong G, van Kempen L, Spatz A. Cytology cell blocks

are suitable for immunohistochemical testing for PD-L1 in lung cancer. Ann Oncol. 2018 Jun 1;29(6):

1417-1422.

ALBRECHT, S.

Fahiminiya S, Sabbaghian N, Albrecht S, Nadaf J, Callegaro-Filho D, Foukes WD. Ovarian

small cell carcinoma in one pair of monozygous twins.Fam Cancer. 2018 Oct 4

Larouche V, Atkinson J, Albrecht S, Laframboise R, Jabado N, Tabori U, Bouffet E ; international bMMRD consortium.Sustained complete response of recurrent glioblastoma to

combined checkpoint inhibition in a young patient with constitutional mismatch repair

deficiency. Pediatr Blood Cancer 2018 Dec ;65(12) : e27389.

Chong AS, Fahiminiya S, Strother D, Priest J, Albrecht S, Rivera B, Foulkes WD. Revisitng

pleuropulmonary blastoma and atypical choroid plexus papilloma in a young child : DIDER1 syndrome

or not ? Pediatr Blood Cancer. 2018 Oct ;65(10) : e27294.

De Kock L, Fahiminiya S, Fiset PO, Astigarraga I, Nguyen VH, Albrecht S, Foulkes WD. Infantile

Pulmonary Teratoid Tumor.N Engl J Med. 2018 Jun 7 ;378(23) : 2238-2240.

ARSENEAU, J

Piedimonte S, Richer L, Souhami L, Arseneau J, Fu L, Gilbert L, Alfieri J, Jardon K, Zeng XZ. Clinical

significance of isolated tumor cells and micrometastasis in low-grade, stage 1 endometrial cancer. J Surg

Oncol. 2018 Dec ;118(7) :1194-1198.

Wang Y, et al., Arseneau J, Fu L, Diaz LA Jr, Karchin R, Tomasetti C, Kinzer KW, Vogelstein B, Fader

AN, Gilbert L, Papadopoulos N. Evaluation of liquid from the Papanicolaou test and other liquid

biopsies for the detection of endometrial and ovarian cancers. Sci Transl Med. 2018 Mar 21 ;10(433)

Nguyen NMP, et al., Arseneau J, Hovanes K, Clisham R, Lenzi T, Scurry B, Addor MC, Bagga R,

Nendaz GG, Finci V, Poke G, Grimes L, Gregersen N, York K, Bolze PA, Patel C, Mozdarani H,

Puechberty J, Scotchie J, Fardaei M, Harma M, Gardner RJM, Sahoo T, Dudding-Byth T, Srinivasan R,

Sauthier P, Slim R. The genetics of recurrent hytdatidiform moles : new insights and lessons from a

comprehensive analysis of 113 patients. Mod Pathol. 2018 Jul ;31(7) : 1116-1130.

https://www.ncbi.nlm.nih.gov/pubmed/30567230


https://www.ncbi.nlm.nih.gov/pubmed/?term=Alam+El+Din++M


















AUGER, M

Auger M, Brimo F, Kanber Y, Fiset PO, Camilleri-Broët S. A practical guide for ancillary studies in

pulmonary cytologic specimens. Cancer Cytopathol. 2018 Aug; 126 Suppl 8:599-614.




1417-1422.

Wang Y, Auger M, Kanber Y, Caglar D, Brimo F. Implementing the Paris System For Reporting

Urinary Cytology results in a decrease in the rate of the “atypical” category and an increase in its

prediction of subsequent high-grade urothelial carcinoma. Cancer Cytopathol.2018 Mar; 126(3):207-

214.

BAGLOLE, CJ

Guerrina N, Traboulsi H, Eidelman DH,Baglole CJ. The Aryl Hydrocarbon Receptor and the

Maintenance of Lung Health. Int J Mol Sci.2018 Dec 5;19(12).

Kapchinsky S, Vuda M, Miguez K, Elkrief D, de Souza AR,Baglole CJ, Aare S, MacMillan NJ, Baril J,

Rozakis P, Sonjak V, Pion C, Aubertin-Leheudre M, Morais JA, Jagoe RT, Bourbeau J, Taivassalo T,

Hepple RT. Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and

atrophy in chronic obstructive pulmonary disease.J Physiol. 2018 Jul;596(14):2865-2881.

Baglole CJ, Liang F, Traboulsi H, Rico de Souza A, Giordano C, Tauer JT, Rauch F, Petrof BJ.

Pulmonary and diaphragmatic pathology in collagen type lα1 mutant mice with osteogenesis imperfecta.

Pediatr Res.2018 Jun;83(6):1165-1171.

Smith BM, Traboulsi H, Austin JHM, Manichaikul A, Hoffman EA, Bleecker ER, Cardoso WV, Cooper

C, Couper DJ, Dashnaw SM, Guo J, Han MK, Hansel NN, Hughes EW, Jacobs DR Jr, Kanner RE,

Kaufman JD, Kleerup E, Lin CL, Liu K, Lo Cascio CM, Martinez FJ, Nguyen JN, Prince MR, Rennard

S, Rich SS, Simon L, Sun Y, Watson KE, Woodruff PG, Baglole CJ, Barr RG; MESA Lung and

SPIROMICS investigators. Human airway branch variation and chronic obstructive pulmonary disease.

Proc Natl Acad Sci USA.2018 Jan 30;115(5) : E974-E981.

Panariti A, baglole CJ, Sanchez V, Eidelman DH, Hussain S, Olivenstein R, Martin JG, Hamid Q.

Interleukin-17A and vascular remodelling in severe asthma; lackof evidence for a direct role. Clin Exp

Allergy.2018 Apr;48(4) :365-378.

BERNARD C

Saskin A, Alfares A, Bernard C, Blumenkrantz M, Braverman N, Gupta I, Brosnihan KB,Antignac C,

Gubler MC, Morinière V, De Bie I, Bitzan M. Renal tubular dysgenesis and microcolon, a novel

association. Report of three cases. Eur J Med Genet.2018 Jul 31. Pii: S1769-7212(18)30120-4.

BLUMENKRANTZ, M

Saskin A, Alfares A, Bernard C, Blumenkrantz M, Braverman N, Gupta I, Brosnihan KB,Antignac C,

Gubler MC, Morinière V, De Bie I, Bitzan M. Renal tubular dysgenesis and microcolon, a novel

association. Report of three cases. Eur J Med Genet.2018 Jul 31. Pii: S1769-7212(18)30120-4.



















BRIMO, F

Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana

VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB, Cancer

Genome Atlas Research Network, Camargo F, Liang H. Comprehensive Molecular Characterization of

the Hippo Signaling Pathway in Cancer. Cell Rep. 2018 Oct 30;25(5): 1304-1317.

Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, Burnier MM, Brimo F, Kassouf W.

Presence of lymphocyctic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as

prognostic marker in patients after radical cystectomy.PLoS One. 2018 Oct 11;13(10);e0205746.

Korkut A, Zaidi S, Kanchi RS, Rao S, Gough NR, Schultz A, Li X, Lorenzi PL, Berger AC, Robertson

G, Kwong LN, Datto M, Roszik J, Ling S, Ravikumar V, Manyam G, Rao A, Shelley S, Liu Y, Ju Z,

Hansel D, de Velasco G, Pennathur A, Andersen JB, O’Rouke CJ, Ohshiro K, Jogunoori W, Nguyen

BN, Li S, Osmanbeyoglu HU, Ajani JA, Mani SA, Houseman A, Wiznerowicz M, Chen J, Gu S, Ma W,

Zhang J, Tong P, Cherniack AD, Deng C, Resar L; Cancer genome Atlas Research Network, Weinstein

JN, Mishra L, Akbani R.A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in

Mediators of Signaling by the TGF-ß Superfamily. Cell Syst. 2018 Oct 24; 7(4):422-437.e7.

He H, Trpkov K, Martinek P, Isikci OT, Maggi-Galuzzi C, Alaghehbandan R, Gill AJ< Tretiakova M,

Lopez Jl,Williamson SR, Montiel DP, Sperga M, Comperat E, Brimo F, Yilmaz A, Pivovarcikova K,

Micjalova K, Slouka D, Prochazkova K, Hora M, Bonert M, Michal M, Hes O. “High-grade oncocytic

renal tumor”: morphologic, immunohistochemical and molecular genetic study of 14 cases. Virchows

Arch. 2018 Dec;473(6):725-738.

Ouellet V, Aprikian A, Bergeron A, Brimo F, Bristow RG, Chevalier S, Drachenberg D, Fazli L,

Fleshner NE, Gleave M, Karakiewicz P, Klotz L, Lacombe L, Lattouf JB, van der Kwast T, Squire JA,

Latour M, Trudel D, Mes-Masson AM, Saad F. The Terry Fox Research Institute Canadian Prostate

Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.

BMC Urol. 2018 Sep 10;18(1):78.


pulmonary cytologic specimens.Cancer Cytopathol. 2018 Aug;126 Suppl 8:599-614.

Wissing M, Chevalier S, McKercher G, Laprise C, Aprikian S, O’Flaherty A, Scarlata E, Saad F, Carmel

M, Lacombe L, Brimo F, Latour M, Ekindi-Ndongo N, Têtu B, Aprikian A. The relationship between

body-mass index, physical activity, and pathologic and clinical outcomes after radical prostatectomy for

prostate cancer. World J Urol. 2018 Aug 22.

Zakaria AS, Dragomir A, Brimo F, Kassouf W, Tanguay S, Aprikian A. Changes in the outcome of

prostate biopsies after preventive task force recommendation against prostate-specific antigen screening.

BMC Urol.2018 Aug 20; 18(1): 69.

Wissing M, Brimo F, Chevalier S, Scarlata E, McKercher G, O’Flaherty A, Aprikian S, Thibodeau V,

Saad F, Carmel M, Lacombe L, Têtu B, Ekindi-Ndgongo N, Latour M, Trudel D, Aprikian A.

Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized

prostate cancer. BJU Int. 2018 Aug 16.




















Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl

MC, Kim J, Reardon B, Kwok-Shing Ng P, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM,

Mularoni L, Rubio-Perez C, Nagarajan N, Cortés-Ciriano I, Zhou DC, Liang WW,Hess JM,

Yellapantula VD, Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van

Allen EM, Liang H; MC3 Working Group;Cancer Genome Atlas Research Network, Lawrence MS,

Godzik A, Lopez-Bigas N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding

L. Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell 2018 Aug 9; 174(4):

1034-1035.

Kahles A, Lehmann KV, Toussaint NC, Hüser M, Stark SG,Sachsenberg T, Stegle O, Kohlbacher O,

Sander C; Cancer Genome Atlas Research Network, Rätsch G. Comprehensive Analysis of Alternative

Splicing Across Tumors from 8,705 Patients. Cancer Cell. 2018 Aug 13;34(2): 211-224.

Ricketts CJ, Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R,

Beroukhim R, Bottaro DP, Choueri TK, Gibbs RA, Godwin AK, Haake S, Hakimi AA, Henske EP,

Hsieh JJ, Ho TH, Kanchi RS,Krishnan B, Kwiatkowski DJ, Lui w, Merino MJ, Mills GB, Myers J,

Nickerson ML, Reuter VE, Schmidt LS, Shelley CS, Shen H, Shuch B, Signoretti S, Srinivasan R,

Tamboli P, Thomas G, Vincent BG, Vocke CD, Wheller DA, Yang L, Kim WY, Robertson AG; Cancer

Genome Atlas Research Network, Spellman PT, Rathmell WK, Linehan WM. The Cancer Genome

Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Jun

19;23(12): 3698.

Saleeb RM, Farag M, Lichner Z, Brimo F, Bartlett J, Bjarnason G, Finelli A, Rotondo F, Downes MR,

Yousef GM. Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2

enhances its response to targeted molecular therapy. Mol Oncol 2018 Oct;12(10): 1673-1688.

Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan GA, Athanazio D, Abro S, Visram K,

Yilmaz A, Solanki S, Hahn E, Siemens R, Kassouf w, Trpkov K. Prognostic pathological factors in

radical cystectomy after neoadjuvant chemotherapy. Histopathology.2018 Nov;73(5):732-740.

Perron G, Jandaghi P, Solanki S, Safisamghabadi M, Storoz C, Karimzadeh M, Papadakis Ai, Arseneault

M, Scelo G, Banks RE, Tost J, Lathrop M, Tanguay S, Brazma A, Huang S, Brimo F, Najafabadi HS,

Riazalhosseini Y. A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-

Binding Proteins that Govern Cancer Transciptomes. Cell Rep. 2018 May 8;23(6): 1639-1650.

Thorsson V, Gibbs DL,Brown SD, Wolf D, Bortone DS, Ou Yang TH,Porta-Pardo E, Gao GF, Plaisier

CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, Malhotra R, Farshidfar F,

Colaprico A, Parker JS, Mose LE, Vo NS, Liu J, LIU Y, Rader J, Dhankani V, Reynolds SM, Bowlby R,

Califano A, Cherniack AD, Antassiou D, Bedognetti D, Rao A, Chen K, Krasnitz A, Hu H, Malta TM,

Noushmehr H, Pedamallu CS, Bullman S, Ojesina Ai, Lamb A, Zhou W, Shen H, Choueiri TK,

Weinstein JN, Guinney J, Saltz J, Holt RA, Rabkin CE; Cancer Genome Atlas Research Network, Lazar

AJ, Serody JS, Demicco EG, Dsis ML, Vincent BG, Shmulevich L. The Immune Landscape of Cancer.

Immunity. 2018 Apr 17;48(4): 812-830.

Lui J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC,

Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V; Cancer genome Atlas Research

Network, Hu H. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality

Survival Outcome Analytics. Cell 2018 Apr 5;173(2): 400-416.















Chen H, Li c, Peng X, Zhou Z, Weinstein JN; Cancer Genome Atlas Research Network, Liang H,. A

Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell. 2018 Apr 5;173(2):

386-399.

Bailey MH, Tokheim C, Porta-Pardo E, Sengupta S, Bertrand D, Weerasinghe A, Colaprico A, Wendl

MC, Kim J, Reardon B, Ng PK, Jeong KJ, Cao S, Wang Z, Gao J, Gao Q, Wang F, Liu EM, Mularoni L,

Rubio-Perez C, Nagarajan N, Cortés-Cirano I, Zhou DC, Liang WW, Hess JM, Yellapantula VD,

Tamborero D, Gonzalez-Perez A, Suphavilai C, Ko JY, Khurana E, Park PJ, Van Allen EM, Liang H;

MC3 Working Group; Cancer genome Atlas Research Network, Lawrence MS, Godzik A, Lopez-Bigas

N, Stuart J, Wheeler D, Getz G, Chen K, Lazar AJ, Mills GB, Karchin R, Ding L. Comprehensive

Characterization of Cancer Driver Genes and Mutations. Cell 2018 Apr 5;173(2): 371-385.

Huang KL, Mashi RJ, WU Y, Ritter Dl, Wang J, Oh C, Paczkowska M, Reynolds S, Wyczalkowski MA,

Oak N, Scott AD, Krassowski M, Cherniack AD, Houlahan KE, Jayasinghe R, Wang LB, Zhou DC, Liu

D, Cao S, Kim YW, Koire A, McMicheal JF, Hucthagowder V, Kim TB, Hahn A, Wang C, McLellan

MD, Al-Mulla F, Johnson KJ; Cancer Genome Atlas Research Network, Lichtarge O, Boutros PC,

Raphael B, Lazar AJ, Zhang W, Wendl MC, Govindan R, Jain S, Wheeler D, Kulkarni S, Dispersio JF,

Reimand J, Meric-Bernstam F, Chen K, Shmulevich I, Plon SE, Chen F, Ding L. Pathogenic Germline

Variants in 10, 389 Adult Cancers. Cell 2018 Apr 5; 173(2):355-370.

Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kaminska B, Huelsken J,

Omberg L, Gevaert O, Colaprico A, Czerwinska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin

AK, Lazar AJ,; Cancer Genome Atlas Research Network, Stuart JM, Hoadley KA, Laird PW,

Noushmehr H, Wiznerowicz M. Machine Learning Identifies Stemness Features Associated with

Oncogenic Dedifferentiation. Cell. 2018 Apr 5; 173(2):338-354.

Kassouf W, Aprikian A, Saad F, Breau RH, Kulkarni G, Guttman DM, Bagshaw K, Izawa J, Eapen L,

Fairey A, So A, North S, Rendon R, Sridhar SS, Brimo F, Chung P, Drachenberg D, Fradet Y, Jacobsen

N, Morash C, Shayegan B, Gotto G, Zlotta A, Freshner N, Siemens DR, Black PC. Improving patient

journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological

Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care

consensus meeting. Can Urol Assoc J.2018 Jul;12(7):E281-E297.

Makis W, Brimo F, Probst S. Primary Renal Leiomyosarcoma Presenting with Subcutaneous and

Osseous Metastases: Staging Follow-Up with 18F-FDG PET/CT. Nucl Med Mol Imaging. 2018

Feb;52(1): 69-73.

Compérat E, Varinot J, Moroch J, Eymerit-Morin C, Brimo F. A practical guide to bladder cancer

pathology. Nat Rev Urol. 2018 Mar;15(3): 143-154.




214.

Ponte R, Dupuy FP, Brimo F, Mehraj V, Brassard P, Belanger M, Yurchenko E, Jenabian MA, Bernard

NF, Routy JP, ORCHID study group. Characterization of myeloid cell populations in human testes

collected after sex reassignment surgery. J Reprod Immunol. 2018 Feb; 125:16-24.






















Trpkov K, Athanazio D, Magi-Galluzzi C, Yilmaz H, Clouston D, Agaimy A, Williamson SR, Brimo F,

Lopez Jl, Ulamec M, Rioux-Leclercq N, Kassem M, Gupta N, Hartmann A, Leroy X, Bashir SA, Yilmaz

A, Hes O. Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent

multifocality: a study of 28 cases. Histopathology.2018 Apr 72(5): 777-785.

Bramhecha YM, Guérard KP, Rouzbeh S, Scarlata E, Brimo F, Chevalier S, Hamel L, Dragomir A,

Aprikian AG, Lapointe J. Genomic Gain of 16p13.3 in Prostate Cancer Predicts Poor Clinical Outcome

after Surgical Intervention. Mol Cancer Res.2018 Jan;16(1):115-123.

Saleeb RM, Plant P, Tawedrous E, Krizova A, Brimo F, Evans AJ, Wala SJ, Bartlett J, Ding Q, Boles D,

Rotando F, Farag M, Yousef GM. Toward Biological Subtyping of Papillary Renal Cell Carcinoma with

Clinical Implications through Histologic, Immunohistochemical, and Molecular Analysis. Eur Urol

Focus. 2018 Sep;4(5):740-748.

BURNIER, M

Bergeron S, Sanft DM, Zoroquiain P, Esposito E, Arthurs B, Burnier MN Jr. An unusual orbital tumor in

an adult: Granuloma annulare. Am J Opthalmol Case Rep. 2018 Nov 14; 13:9-12.

Isenberg J, Golizeh M, Belfort RN, da Siva AJ, Burnier MN, Ndao M. Peptidyl-prolyl cis-trans

isomerase A-A novel biomarker of multi-episodic (recurrent) ocular toxoplasmosis. Exp Eye Res. 2018

Dec;177:104-111.

Mastromonaco C, Balazsi M, Zoroquiain P, Esposito E, Coblentz J, Logan P, Burnier MN. Removing

Subjective Post-Mortem Grading from Posterior Capsular Opacification: A New Automated Detector

Opacification Software, ADOS. Curr Eye Res. 2018 Nov;43(11): 1362-1368.

Miyamoto D, Dias ABT, Aoki V, Burnier MN Jr. Beta-adrenoceptor expression in pemphigus foliaceus.

J Eur Acad Dermatol Venereol. 2018 Dec;32(12): e459-e461.

Pinto Proença R, Fernandes J, Burnier MN, Proença R. Orbital metastasis from an occult breast

carcinoma (T0,N1, M1). BMJ Case Rep. 2018 Apr 11;2018.pii: bcr-2017-223542.

Zoroquiain P, Esposito E, Logan P, Aldrees S, Diab AB, Mansure JJ, Santapau D, Garcia C, Saornil

MA, Belfort Neto R, Burnier MN.Programmed cell death ligand-1 expression in tumor and immune cells

is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal

melanoma. Mod Pathol.2018 Aug;31(8):1202-1210.5

Andrade GC, Dias JRO, Maia A, Kanecadan LA, Moraes NSB, Belfort Junior R, Lasiste JME, Burnier

MN. Intravitreal Angiostrongylus cantonensis: first case report in South America. Arq Bras Oftalmol.

2018 Jan-Feb;81(1): 63-65.

Zoroquiain P, Mastromonaco C, Balaszi M, Lasiste J, Aldrees S, Saheb N, Burnier MN Jr.

Histopathological trabecular meshwork remodeling after cataract surgery detected with an advanced

image analyzer. J cataract Refract Surg. 2018 Jan; 44(1): 98-102.

Miyamoto D, Maruta CW, Santi CG, Zoroquiain P, Dias ABT, Mansure JJ, Burnier MN Jr, Aoki V.

Exploring the in situ expression of vascular endothelial growth factor and endoglin in pemphigus

foliaceus variants and pemphigus vulgaris.J Eur Acad Dermatol Venereol.2018 Nov;32(11): 1954-1958.

























Zoroquiain P, Sanft DM, Esposito E, Cheema D, Dias AB, Burnier MN Jr. High Inflammatory Infiltrate

Correlates with Poor Symptomatic Improvement after Surgical Treatment for Superior Limbic

Keratoconjunctivitis. Cornea 2018 Apr;37(4): 495-500.

CAGLAR, D




214.

CAMILLERI-BROET, S






1417-1422.

DIVANGAHI, M

Divangahi M, Khan N, Kaufmann E. Beyond Killing Mycobacterium tuberculosis: Disease Tolerance.

Front Immunol. 2018 Dec 19; 9:2976.

Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonça LE, Pacis A, Tzelepis F, Pernet E, Dumaine A,

Grenier JC, Mailhot-Léonard F, Ahmed E, Belle J, Besla R, Mazer B, King iL Nijnik A, Robbins CS,

Barreiro LB, Divangahi M. BCG Educates Hematopoietic Stem Cells To Generate Protective Innate

Immunity against Tuberculosis. Cell. 2018 Jan 11;172(1-2): 176-190.

Roussel L, Landekic M, Golizeh M, Gavino C, Zhong MC, Chen J, Faubert D, Blanchet-Cohen A,

Dansereau L, Parent MA, Marin S, Luo J, Le C, Ford BR, Langelier M, King IL, Divangahi M, Foulkes

WD, Veillette A, Vinh DC. Loss of human ICOSL results in combined immunodeficiency. J Exp Med.

2018 Dec 3; 215(12):3151-3164.

Divangahi M. Are tolerance and training required to end TB? Nat Rev Immunol. 2018 Nov;18(11): 661-

663.

Chennakrishnaiah S, Meehan B, D’Asti E, Montermini L, Lee TH, Karatzas N, Buchanan M, Tawil N,

Choi D, Divangahi M, Basik M, Rak J. Leukocyctes as a reservoir of circulating oncogenic DNA and

regulatory targets of tumor-derived extracellular vesicles.J Thromb Haemost.2018 Sep;16(9):1800-1813.

Tzelepis F, Blagih J, Khan N, Gillard J, Mendonca L, Roy DG, Ma EH, Joubert P, Jones RG, Divangahi

M. Mitochondrial cyclophilin D regulates T cell metabolic responses and disease tolerance to

tuberculosis. Sci Immunol. 2018 May 11;3(23).

Downey J, Pernet E, Coulombe F, Divangahi M. Dissecting host cell death programs in the pathogenesis

of influenza. Microbes Infect. 2018 Oct-Nov;20(9-10): 560-569.

Khan N, Divangahi M. Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to

macrophages.J Infect Dis.2018 May 25;217(12):1851-1853.
























Kim JH, Podstawka J, Lou Y, Li L, Lee EKS, Divangahi M, Petri B, Jirik FR, Kelly MM, Yipp BG.

Aged polymorphonuclear leukocytes cause fibrotic interstitial lung disease in the absence of regulation

by B cells. Nat Immunol. 2018Feb;19(2): 192-201.

Divangahi M, Behr MA. Cracking the Vaccine Code in Tuberculosis. Am J Respir Crit Care Med.2018

Feb 15;197(4):427-432.

FISET, PO Auger M, Brimo F, Kanber Y, Fiset PO, Camilleri-Broët S. A practical guide for ancillary studies in


deKock L, Fahiminiya S, Fiset PO, Astigarraga I, Nguyen VH, Albrecht S, Foulkes WD.

Infantile Pulmonary Teratoid Tumor. N Engl J Med. 2018 Jun 7 ;378(23) : 2238-2240.

Wang H, Agulnik J, Kasymjanova G, Wang A, Jiménez P, Cohen V, Small D, Pepe C, Sakr L,

Fiset PO, Auger M, Camilleri-Broët S, Alam El Din M, Chong G, vanKempen L, Spatz A.

Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer.

Ann Oncol. 2018 Jun 1 ;29(6) : 1417-1422.

FLOREA, A Turkdogan S, Forest VI, Hier MP, Tamilia M, Florea A, Payne RJ. Carcinoembryonic antigen

levels correlated with advanced disease in medullary thyroid cancer.J Otolaryngol Head Neck

Surg. 2018 Sep 17;47(1):55.

FLORIANOVA, L

Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T. Do

clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant

therapy? Int J Colorectal Dis. 2018 Jun;33(6): 727-733.

FRASER, R.

Totten S, Fraser R. Narratives of the museum specimen: a pilot project. Med Educ. 2018

Nov;52(11): 1186.

Roy CF, Roy SF, Richer L, Fraser R, Gilman S. Sevelamer Aspiration. J Bronchology Interv

Pulmonol. 2018 Jul;25(3): e36-e37.

GAO, ZH

Su Q, Zhu EC, Qu YL, Wang DY, Qu WW, Zhang CG, Wu T, Gao ZH. Serum level of co-expressed

hub miRNA as diagnostic and prognostic biomarkers for pancreatic ductal adenocarcinoma.J Cancer.

2018 Oct 11;9(21) : 3991-3999.

Song ZY, Wang F, Cui SX, Gao ZH, Qu XJ. CXCR7/CXCR4 heterodimer-induced histone demethylation:

a new mechanism of colorectal tumorigenesis. Oncogene. 2019 Feb;38(9): 1560-1575.

Su Q, Zhang X, Shen X, Hou Y, Sun Z, Gao ZH. Risk of immune-related colitis with PD-1/PD-L1

inhibitors vs chemotherapy in solid tumors: systems assessment. J Cancer. 2018 Apr 12;9(9): 1614-1622.





















Su Q, Zhang XC, Wang DY, Zhang HR, Zhu C, Hou YL, Liu JL, Gao ZH. The risk of immune-related

endocrine disorders associated with anti-PD-1 inhibitors therapy for solid tumors: A systematic review

and meta-analysis. Int Immunopharmacol.2018 Jun;59:328-338.

Lazaris A, Amri A, Petrillo SK, Zoroquiain P, Ibrahim N, Salman A, Gao ZH, Vermeulen PB, Metrakos

P. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-

angiogenic therapies. J Pathol Clin Res. 2018 Jul;4(3):184-192.

Huang R, Gao ZH, Tang A, Sebastiani G, Deschenes M. Transient elastography is an unreliable marker

of liver fibrosis in patients with portal vein thrombosis. Hepatology. 2018 Aug;68(2):783-785.

Zhao L, Westerhoff M, Pai RK, Choi WT, Gao ZH, Hart J. Centrilobular ductular reaction correlates

with fibrosis progression in non-alcoholic steatohepatitis. Mod Pathol. 2018 Jan;31(1): 150-159.

Tan YG, Wang XF,Zhang M, Yan HP, Lin DD, Wang YQ, Zhang HP, Yu XQ, Liao HY, Wang YP, Lv

FD, Gao ZH. Clonal charcteristics of paired infiltrating and circulating B lymphocyte repertoire in

patients with primary biliary cholangitis. Liver Int. 2018 Mar;38(3): 542-552.

GUIOT, MC Dankner M, Lajoie M, Moldoveanu D, Nguyen TT, Savage P, Rajikumar S, Huang X, Lvova M,

Protopopov A, Vuzman D, Hogg D, Park M, Guiot MC, Petrecca K, Milhalcioiu C, Watson IR,

Siegel PM, Rose AAN. Dual MAPK Inhibition is an Effective Therapeutic Strategy for a Subset of

Class II BRAF Mutant Melanomas.Clin Cancer Res. 2018 Dec 15;24(24): 6483-6494.

Knight JF, Sung VYC, Kuzmin E, Couzans AL, de Verteuil DA, Ratcliffe CDH, Coelho PP,

Johnson RM,Samavarchi-Tehrani P, Gruosso T, Smith HW, Lee W, Saleh SM, Zuo D, Zhao H,

Guiot MC, Davis RR, Gregg JP, Moraes C, Gingras AC, Park M.KIBRA(WWC1) is A Metastasis

Suppressor gene affected by Chromosome 5g Loss in Triple-Negative Breast Cancer. Cell Rep

2018 Mar 20;22(12): 3191-3205.

Desroches J, Jermyn M, Pnto M, Picot F, Tremblay MA, Obaid S, Marple E, Urmey K, Trudel D,

Soulez G, Guiot MC, Wilson BC, Petrecca K, Leblond F. A new method using Raman

spectroscopy for in vivo targeted brain cancer tissue biopsy. Sci Rep. 2018 Jan 29;8(1): 1792.

Shakir Sl, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-

Odaini AA, Abdulkarim B, Guiot MC. Prognostic factors for progression in atypical meningioma.

J Neurosurg. 2018 Nov 1;129(5): 1240-1248.

Kaur S, Ramdzan ZM, Guiot MC, Li L, Leduy L, Ramotar D, Sabri S, Abdulkarim B, Nepveu A.

CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the

monoalkylating agent temozolomide. Neuro Oncol. 2018 Mar 27; 20(4): 484-493.

Bernhardt BC, Fadaie F, Vos de Wael R, Hong SJ, Liu M, Guiot MC, Rudko DA, Bernasconi A,

Bernasconi N. Preferential susceptibility of limbic cortices to microstructural damage in temporal

lobe epilepsy: A quantitative T1 mapping study. Neuroimage. 2018 Nov 15; 182:294-303.























HUSSAIN, S

Gouspillou G, Godin R, Piquereau J, Picard M, Mofarrahi M, Mathew J, Purves-Smith FM, Sgarioto N,

Hepple RT, Burelle Y, Hussain SNA. Protective role of Parkin in skeletal muscle contractile and

mitochondrial function. J Physiol 2018 Jul;596(13):2565-2579.

JABADO, N

Khater F, Langlois S, Cassart P, Roy AM, Lajoie M,Healy J, Richer C, St-Onge P, Piché N, Perreault S,

Cellot S, Marzouki M, Jabado N, Sinnett D.Recurrent somatic BRAF insertion (p.V504_R506dup): a

tumor marker and a potential therapeutic target in pilocytic astrocytoma. Oncogene. 2018 Dec 21. doi:

10.1038.

Gomes CC, Gayden T, Bajic A, Harraz OF, Pratt J, Nikbakht H, Bareke E, Diniz MG, Castro WH, St-

Onge P, Sinnett D, Han H, Rivera B, Mikael LG, De Jay N, Kleinman CL, Valera ET, Bassenden AV,

Berghuis AM, Majewski J, Nelson MT, Gomez RS, Jabado N. TRPV4 and KRAS and FGFR1 gain-of-

function mutations drive giant cell lesions of the jaw. Nat Commun. 2018 Nov 1;9(1): 4572.

Gayden T, et al. Jabado N. Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous

panniculitis-like T cell lymphomas with hemophagocyctic lymphohistiocytic syndrome.Nat Genet. 2018

Nov 14.

Larouche V, Atkinson J, Albrecht S, Laframboise R, Jabado N, Tabori U, Bouffet E ; international bMMRD consortium.Sustained complete response of recurrent glioblastoma to

combined chekcpoint inhibition in a young patient with constitutional mismatch repair

deficiency. Pediatr Blood Cancer 2018 Dec ;65(12) : e27389.

Valera ET, McConechy MK, Gayden T, Rivera B, Jones DTW, Wittmann A, Han H, Bareke E,

Nikbakht H, Mikael L, Queiroz RG, Suazo VK, Phi JH, Kim SK, Park SH, Fukaya R, Yum MS, Ko TS,

de Olivera RS, Machado HR, Brassesco MS, do Santos AC, Simão GN, Ramalho LNZ, Neder L,

Scrideli CA, Tone LG, Majewski J, Jabado N. Methylome analysis and whole-exome sequencing reveal

that brain tumors associated with encephalocraniocutaneous lipomatosis are midline pilocytic

astrocytomas. Acta Neuropathol. 2018 Oct;136(4): 657-660.

Kondyli M, Larouche V, Saint-Martin C, Ellezam B, Pouliot L, Sinnett D, legault g, Crevier L, Weil A,

Farmer JP, Jabado N, Perreault S. Trametinib for progressive pediatric low-grade gliomas. J

Neurooncol.2018 Nov;140(2):435-444.

Garzia L, et al. Jabado N, Zapotocky M, Sumerauer D, Bouffet E, Dirks P, Tabori U, Sorensen PHB,

Brastianos PK, Aldape K, Jones SJM, Marra MA, Woodgett JR, Wechsler-Reya RJ, Fults DW, Taylor

MD. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases. Cell 2018 May

31;173(6):1549.

Waszak SM, et al. Jabado N, et al. Pfister SM. Spectrum and prevalence of genetic predisposition in

medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

Lancet Oncol. 2018 Jun;19(6): 785-798.

Hoffman LM, et al. Jabado N, et al., Fouladi M. Clinical, Radiologic, Pathologic and Molecular

Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma(DIPG) : A Collaborative

Report From the International and European Society for Pediatric Oncology DIPG Registries. J Clin

Oncol. 2018 Jul 1 ;36(19) : 1963-1972.






















Capper D, et al. Jabado N, et al. Pfister SM. DNA methylation-based classification of central nervous

tumors.Nature 2018 Mar 22;555(7697): 469-474.

Garzia L, et al. Jabado N, et al., Taylor MD. A hematogenous Route for Medulloblastoma

Leptomeningeal Metastases. Cell 2018 Feb 22 ;172(5) : 1050-1062.

Gómez S, Garrido-Garcia A, Garcia-Gerique L, Lemos I, Suñol M, de Torres C, Kulis M, Pérez-Jaume

S, Carcaboso ÁM, Luu B, Kieran MW, Jabado N, Kozlenkov A, Dracheva S, Ramaswamy V, Hovestadt

V, Johann P, Jones DTW, Pfister SM, Morales La madrid A, Cruz O, Taylor MD, Martin-Subero Jl,

Mora J, Lavarino C. A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma.Clin

Cancer Res. 2018 Mar 15 ;24(6) : 1355-1363.

Mack SC, et al., Jabado N, Rutka JT, Northcott PA, Lupien M, Lichter P, Korshunov A, Scacheri PC,

Pfister SM, Kool M, Taylor MD, Rich JN. Therapeutic targeting of ependymoma as informed by

oncogenic enhancer profiling.Nature.2018 Jan 4 ;553(7686) : 101-105.

Jones DTW, Kieran MW, Bouffet E, Alexandrescu S, Bandopadhayay P, Bornhorst M, Ellison D,

Fangusaro J, Fisher MJ, Foreman N, Fouladi M, Hargrave D, Hawkins C, Jabado N, Massimino M,

Muelller S, Perilongo G, Schouten van Meeteren AYN, Tabori U, Warren K, Waanders AJ, Walker D,

Weiss W, Witt O, Wright K, Zhu Y, Bowers DC, Pfister SM, Packer RJ. Pediatric low-grade gliomas:

next biologically driven steps. Neuro Oncol. 2018 Jan 22;20(2): 160-173.

KANBER, Y






214.

KARAMCHANDANI, J Costiniuk CT, Karamchandani J, Bessissow A, Routy JP, Szabo J, Frenette C. Angiocentric lymph

proliferative disorder (lymphomatoid granulomatosis) in a person with newly-diagnosed HIV infection: a

case report. BMC Infect Dis. 2018 May 8;18(1):210.

Gauthier J, Meijer IA, Lessel D, Mencacci NE, Krainc D, Hempel M, Tsiakas K, Prokisch H, Rossignol

E, Helm MH, Rodan LH, Karamchandani J, Carecchio M, Lubbe SJ, Telegrafi A, Henderson LB,

Lorenzo K, Wallace SE, Glass IA, Hamdan FF, Michaud JL, Rouleau GA, Campeau PM. Recessive

mutations in >VPS13D cause childhood onset movement disorders. Ann Neurol 2018 Jun;83(6):1089-

1095.

Barbacki A, Fallavollita SA, Karamchandani J, Hudson M. Immune-Mediated Necrotizing Myopathy

and Dietary Sources of Statins. Ann Intern Med. 2018 Jun 19;168(12):893-904.

KASSOUF W

Violette PD, Lavallée LT, Kassouf W, Gross PL, Shayagan B. Canadian Urological Association

guideline on perioperative thromboprophylaxis and management of anticoagulation. Can Urol Assoc J.

2018 Dec 14.
























Oleik G, Kassouf W, Aprikian A, Hu J, Vanhuyse M, Cury F, Peacock S, Bonnevier E, Palenius E,

Dragomir A. Evaluation of New Tests and Interventions for Prostate Cancer Management: A Systematic

Review. J Natl Compr Canc Netw. 2018 Nov;16(11):1340-1351.

El-Achkar A, Souhami L, Kassouf W. Bladder preservation Therapy: Review of Literature and Future

Directions of Trimodal Therapy. Curr Urol Rep. 2018 Nov 3;19(12):108.

Yu A, Mansure JJ, Solanki S, Siemens DR, Koti M, Dias ABT, Burnier MM, Brimo F, Kassouf W.

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3+, CD8+, and immunoscore as

prognostic marker in patients after radical cystectomy .PLoS One. 2018 Oct 11;13(10)

Kassouf W, Monteiro LL, Drachenberg DE, Fairey AS, Finelli A, Kapoor A, Lattouf JB, Leveridge MJ,

Power NE, Pouliot F, Rendon RA, Sabbagh R, So Al, Tanguay S, Breau RH. Canadian Urological

Association guideline for follow up of patients after treatment of non-metastatic renal cell carcinoma.

Can Urol Assoc J. 2018 Aug;12(8): 231-238.

Zakaria AS, Dragomir A, Brimo F, Kassouf W, Tanguay S, Aprikian A. Changes in the outcome of

prostate biopsies after preventive task force recommendation against prostate-specific antigen screening.

BMC Urol. 2018 Aug 20;18(1):69.

Klaassen Z, Karnat AM, Kassouf W, Gontero P, Villavicencio H,Bellmut J, van Rhijin BWG, Hartmann

A, Catto JWF, Kulkarni GS. Treatment Strategy for Newly Diagnosed T1 High-grade Bladder Urothelial

Carcinoma: New Insights and Updated Recommendations. Eur Urol.2018 Nov;74(5):597-608.

Karakiewicz Pl, et al. Kassouf W, et al. Bandini M. Kidney Cancer Research Network of Canada

consensus statement on the role of adjuvant therapy after nephrectomy for high-risk, non-metastatic

renal cell carcinoma: A comprehensive analysis of the literature and meta-analysis of randomized

controlled trials. Can Urol Assoc J.2018 Jun;12(6):173-180.

Brimo F, Downes MR, Jamaspishvili T, Berman D, Barkan GA, Athanazio D, Abro S, Visram K,Yilmaz

A. Solanki S, Hahn E, Siemens R, Kassouf W, Trpkov K. Prognostic pathological factors in radical

cystectomy after neoadjuvant chemotherapy. Histopathology. 2018 Nov;73(5): 732-740.

Locke JA, Hamidizadeh R, Kassouf W, Rendon RA, Bell D, Izawa J, Chin J, Kapoor A, Shayegen B,

Lattouf JB, Saad F, Lacombe L, Fradet Y, Fairey AS, Jacobson NE, Drachenberg DE, Cagiannos I, So

Al, Black PC. Surveillance guidelines based on recurrence patterns for upper tract urothelial carcinoma.

Can Urol Assoc J. 2018 Aug; 12(8): 243-251.

Kassouf W, Aprikian A, Saad F, Breau RH, Kulkarni G, Guttman DM, Bagshaw K, Izawa J, Eapen L,

Fairey A, So A, North S,Rendon R, Sridhar SS, Brimo F, Chung P, Drachenberg D, Fradet Y, Jacobsen

N, Morash C, Shayegan B, Gotto G, Zlotta A, Freshner N, Siemens DR, Black PC. Improving patient

journey and quality of care: Summary from the second Bladder Cancer Canada-Canadian Urological

Association-Canadian Urologic Oncology Group (BCC-CUA-CUOG) bladder cancer quality of care

consensus meeting. Can Urol Assoc J. 2018 Jul;12(7): E281-E297.
























Zakaria AS, Dragomir A, Kassouf W, Tanguay S, Aprikian A. Changes in the levels of testosterone

profile over time in relation to clinical parameters in a cohort of patients with prostate cancer managed

by active surveillance. World J Urol. 2018 Aug;36(8): 1209-1217.

Cumberbatch MGK, Foerster B, Catto JWF, Kamat AM, Kassouf W, Jubber l, Shariat SF, Sylvester RJ,

Gontero P. Repeat Transurethral Resection in Non-muscle-invasive Bladder Cancer: A Systematic

Review. Eur Urol. 2018 Jun;73(6):925-933.

El-Achkar A, Kassouf W. Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing

Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic. Eur Urol. 2018

May;73(5):810-811.

Zargar H, Shah JB, van Rhijin BW, Daneshmand S, Bivalacqua TJ, Spiess PE, Black PC, Kassouf W;

Collaborators. Neoadjuvant Dose Dense MVAC versus Gemcitabine and Cisplatin in Patients with cT3-

4aNOMO Bladder Cancer Treated with Radical Cystectomy. J Urol. 2018 Jun;199(6):1452-1458.

Kassouf W. Editorial Comment. J Urol.2018 Feb;199(2):415.

Hermans TJN, Voskuilen CS, van der Heijden MS, Schmitz-Dräger BJ, Kassouf W, Seiler R, Kamat

AM, Grivas P, Kiltie AE, Black PC, van Rhijin BWG. Neoadjuvant treatment for muscle-invasive

bladder cancer: The past, the present and the future. Urol Oncol.2018 Sep;36(9): 413-422.

METRAKOS, P

ChenYI, Miller CS, hashim A, Valenti D, Metrakos P, Barkun J, Zogopoulos G, Barkun AN, Bessissow

A. EUS-IR-Guided Revision of Whipple Anatomy for Concomitant Afferent and Efferent Limb

Obstruction.Am J Gastroenterol.2018 Dec;113(12): 1747.

Hallet J, Jayaraman S, Martel G, Ouellet JB,Lin Y, McCluskey S, Beyfuss KA, Karanicolas PJ;

Canadian Hepato-Pancreatico Bilary Association group.Pateint blood management for liver resection:

consensus statements using Delphi methodology. HPB(Oxford).2018 Nov 13.pii:S1365-182X(18)34472-

1.

Lazaris A, Amri A, Petrillo SK, Zoroquiain P, Ibrahim N, Salman A, Gao ZH, Vermeulen PB, Metrakos

P. Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-

angiogenic therapies. J Patholo Clin Res. 2018Jul;4(3):184-192.

Hashim A, Chen Yl, Valenti D, Metrakos P, White S, Barkun A, Bessissow A. Endosonography-guided

hepatogastrostomy post-percutaneous bilary drainage in collaboration with interventional radiology.

Endoscopy. 2018 May ;50(5) :E115-E116.

MICHEL, R Chen J, Mehraj V, Szabo J, Routy B, Michel RP, Routy JP. Multiple remissions of extracavity primary

effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.

Curr Oncol. 2018 Dec;25(6): e592-e596.

Courteau C, Khoury A, Michel RP, Weber CL. Acute hemodialysis in a young man with severe

symptomatic hyponatremia and kidney injury. Hemodial Int. 2018 Jul: 22(3):E45-E48.

























OMEROGLU, A Chamming’s F, Ueno Y, Aldis A, Seidler M, Mesurolle B, Omeroglu A, Gallix B, Reinhold C.

Enhancement of breast cancer on pre-treatment dynamic contrast-enhanced MRI using computer-aided

detection is associated with response to neo-adjuvant chemotherapy. Diagn Inter Imaging. 2018

Dec;99(12): 773-781.

Wong SM, Prakash I, Trabulsi N, Paysan A, Moldoveanu D, Zhang D, Mesurolle B, Omeroglu A, Aldis

A, Meterissian S. Evaluating the Impact of Breast Density on Preoperative MRI in Invasive Lobullar

Carcinoma. J Am Coll Surg.2018 May; 226(5):925-932.

PARK, M Bernier C, Soliman A, Gravel M., Danker M, Savage P, Petrecca K, Park M, Siegel P M, Shore GC,

Roulston A. DZ-2384 has a superior preclinical profile to taxanes for the treatment of triple-negative breast

cancer and is synergistic with anti-CTLA-4 immunotherapy. Anticancer Drugs 2018 29(8): 774-785.

Dankner M, Lajoie M, Moldoveanu D, Nguyen TT, Savage P, Rajikumar S, Huang X, Lvova M,

Protopopov A, Vuzman D, Hogg D, Park M, Guiot MC, Petrecca K, Milhalcioiu C, Watson IR, Siegel

PM, Rose AAN. Dual MAPK Inhibition is an Effective Therapeutic Strategy for a Subset of Class II BRAF

Mutant Melanomas.Clin Cancer Res. 2018 Dec 15;24(24): 6483-6494.

Goyette MA, Duhamel S, Aubert L, Pelletier A, Savage P, Thibault MP, Johnson RM, Carmeliet P, Basik

M, Gaboury l, Muller WJ, Park M, Roux PP, Gratton JP, Cote JF. The Receptor Tyrosine Kinase AXL is

required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression.

Cell Rep. 2018 23(5):1476-1490.

Hirukawa A, Smith HW, Zuo D, Dufour CR, Savage P, Berthos N, Johnson RM, Bui T, Bourque G, Basik

M, Giguere V, Park M, Muller WJ. Targeting EZH2 reactivates a breast cancer subtype-specific anti-

metastatic transcriptional program. Nat Commun 2018 9(1): 2547.

Klauschen F, et al. ,Park M, et al. International Immuno-Oncology Biomarker Working Group. Scoring

of tumor-infiltrating lymphocyctes: From visual estimation to machine learning. Semin Cancer Biol.

2018. 52(Pt 2): 151-157.

Knight JF, et al. Park M.KIBRA (WWC1) Is a Metastasis Suppressor Gene affected by Chromosome 5q

Loss in Triple-Negative Breast Cancer. Cell Rep. 2018 22(12):3191-3205.

Manem V, Adam GA, Grusso T, Gigoux M, Berthos N, Park M, Haibe-Kains B. CrosstalkNet: A

Visualization Tool for Differential Co-expression Networks and Communities. Cancer Res. 2018 78(8):

2140-2143.

Murali B, Ren Q, et al. Park M, Mbalaviele G, Monahan J, Stewart SA. Inhibition of the stromal

p38MAPK/MK2 pathway limits breast cancer metastases and chemotherapy-induced bone loss. Cancer

Res. 2018 78(19): 5618-5630.

Robichaud N, Hsu BE, Istomine R, Alvarez F, Blagih J, Ma EH, Morales SV, Dai D, Li G, Souleimanova

M, Guo Q, Del Rincon SV, Miller WH Jr.,Ramon YCS, Park M, Jones RG, Piccirillo CA, Siegel PM,





















Sonenberg N. Translational control in the tumor microenvironment promotes lung metastasis:

Phosphorylation of eIF4E in neutrophils. Proc Natl Acad Sci USA. 2018 115(10): E2202-E2209.

Sizemore GM, Balakrishnan S, Thies KA, Hammer AM, Sizemore ST, Trimboli AJ, Cuitino MC, Steck

SA, Tozbikian G, Kladney RD, Shinde N,Das M, et al., Park M, Leone G, Ostrowski MC. Stromal PTEN

determines mammary epithelial response to radiotherapy. Nat Commun 2018 9(1):2783.

Findlay S, Heath J, Luo VM, Malina A, Morin T, Coulombe Y, et al., Park M, Côté JF, Masson JY,

Maréchal A, Orthwein A. SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-stranded

break repair pathway choice. EMBO J. 2018 Sep 14:37(18).

PELMUS, M

Kogan L, Octeau D, Amajoud Z, Abitbol J, Laskov I, Ferenczy A, Pelmus M, Eisenberg N, Kessous R,

Lau S, Yasmeen A, Gotlieb WH, Salvador S. Impact of lower uterine segment involvement in typeII

endometrial cancer and the unique mutational profile of serous tumors. Gynecol Oncol Rep. 2018 Mar

19; 24:43-47.

Kessous R, Oncteau D, Klein K, Tonin PN, Greenwood CMT, Pelmus M, Laskov I, Kogan L, Salvador

S, Lau S, Yasmeen A, Gotlieb WH. Distinct homologous recombination gene expression profiles after

neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer. Gynecol

Oncol. 2018 Mar;148(3): 553-558.

PUSZTASZERI M Sadowski SM, Pusztaszeri M, Brulhart-Meynet MC, Petrenko V, De Vito C, Sobel J, Delucinge-Vivier

C, Kebebew E, Regazzi R, Philippe J, Triponez F, Dibner C. Identification of Differential

Transcriptional Patterns in Primary and Secondary Hyperparathyroidism. J Clin Endocrinol Metab. 2018

Jun 1;103(6): 2189-2198.

Podetta M, Pusztaszeri M, Toso C, Procopiou M, Triponez F, Sadowski SM. Oncocytic Adrenocortical

Neoplasm with Concomitant Papillary Thyroid Cancer. Front Endocrinol(Lausanne). 2018 Jan 22;8:384.

Arnoux G, Pusztaszeri M. “Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear

Features” With Focal Spindle Cell Metaplasia. Int J Surg Pathol. 2018 May;26(3): 261-265.

Pusztaszeri M, Baloch Z, Vielh P, Faquin WC. Application of the Milan system for reporting risk

stratification in salivary gland cytopathology. Cancer Cytopathol. 2018 Jan;126(1): 69-70.

Becker M, Varoquaux AD, Conbescure C, Rager O, Pusztaszeri M, Burkhardt K, Delattre BMA,

Dulguerov P, Dulguerov N, Katirtzidou E, Caparrotti F, Ratib O, Zaidi H, Becker CD. Local recurrence

of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of

FDG_PET/MRI with diffusion-weighted sequences. Eur Radiol. 2018 Feb;28(2): 651-663.

SABRI, S Kaur S, Ramdzan ZM, Guiot MC, Li L, Leduy L, Ramotar D, Sabri S, Abdulkarim B, Nepveu A.

CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the

monoalkylating agent temozolomide. Neuro Oncol. 2018 Mar 27; 20(4): 484-493.
























Leech AO, Vellanki SH, Rutherford EJ, Keogh A, Jahns H, Hudson L, O’Donovan N, Sabri S,

Abdulkarim B, Sheehan KM, Kay EW, Young LS, Hill ADK, Smith YE, Hopkins AM. Cleavage of the

extracellular domain of junctional adhesion molecule-A is associated with resistance to anti-HER2

therapies in breast cancer settings. Breast cancer Res. 2018 Nov 20;20(1): 140.

Chaddad A, Sabri S, Niazi T, Abdulkarim B. Prediction of survival with multi-scale radiomic analysis in

glioblastoma patients. Med. Biol Eng Comput. 2018 Dec;56(12):2287-2300.

SPATZ, A Wang H, Spatz A. Making cytology specimens solid materials for testing predictive marker of

immunotherapy in NSCLC. Oncotarget. 2018 Oct 26;9(84):35472-35473.

Stockley T, Souza CA, Cheema PK, Melosky B, Kamel-Reid S, Tsao MS, Spatz A, Karsan A. Evidence-

based best practices for EGFR T790M testing in lung cancer in Canada. Curr Oncol. 2018

Apr;25(2):163-168.

Popp R, Basik M, Spatz A, Batist G, Zahedi RP, Brichers CH. How iMALDI can improve clinical

diagnostics. Analyst.2018 May 15;143(10): 2197-2203.

Van Kempen LC, Wang H, Aquirre ML, Spatz A, Kasymjanova G, Vilacha JF, Groves MR, Agulik J,

Small D. Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC.J Thorac

Oncol.2018 Sep;13(9): e161-e163.

Wang H, Agulik J, Kasymjanova G, Wang A, Jiménez P, Cohen V, Small D, Pepe C, Sakr L, Fiset PO,


are suitable for immunohistochemical testing for PD-L1 in lung cancer. Ann Oncol. 2018 Jun

1;29(6):1417-1422.

Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N, Vasilevsky CA, Vuong T. Do

clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant

therapy? Int J Colorectal Dis. 2018 Jun;33(6): 727-733.

WANG, H

Wang H, Spatz A. Making cytology specimens solid materials for testing predictive marker of

immunotherapy in NSCLC. Oncotarget. 2018 Oct 26;9(84):35472-35473.

Van Kempen LC, Wang H, Aquirre ML, Spatz A, Kasymjanova G, Vilacha JF, Groves MR, Agulik J,

Small D. Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC. J Thorac

Oncol.2018 Sep;13(9): e161-e163.

Wang H, Agulik J, Kasymjanova G, Wang A, Jiménez P, Cohen V, Small D, Pepe C, Sakr L, Fiset PO,


are suitable for immunohistochemical testing for PD-L1 in lung cancer. Ann Oncol. 2018 Jun

1;29(6):1417-1422.

WATTERS, AK

Al Ali A, Alkhodair R, Thuraisingam T, Gerstein W, Watters K. Multiple granuloma annulare lesions

presenting simultaneously with herpes zoster infection: Wolf’s isotopic response. JAAD Case Rep. 2018

Jul 20;4(7): 631-632.

























Roy SF, Ghazawi FM, Alsarheed A, Lach KD, Watters K, O’Brien E. Angiosarcoma arising within a non-

functioning arteriovenous fistula. Int J Dermatol. 2018 Dec;57(12):1513-1515.

Aljenedil S, Ruel I, Watters K, Genest J. Severe xanthomatosis in heterozygous familial

hypercholesterolemia. J Clin Lipidol 2018 Jul-Aug; 12(4): 872-877.





Documents

Publication List Jan 2018-Dec 2018 Department of Pathology ... · Wang Y, Auger M, Kanber Y, Caglar D, Brimo F. Implementing the Paris System For Reporting Urinary Cytology results